Executive functioning in 6 year old children exposed to chemotherapy in utero.

[1]  E. Cardonick,et al.  Being a mother after a cancer diagnosis during pregnancy: Maternal psychosocial functioning and child cognitive development and behavior , 2020, Psycho-oncology.

[2]  L. Lagae,et al.  Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy , 2019, Annals of Oncology.

[3]  G. Pravettoni,et al.  Psychological issues and construction of the mother-child relationship in women with cancer during pregnancy: a perspective on current and future directions , 2018, BMC psychology.

[4]  B. van Calster,et al.  Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. , 2018, The Lancet. Oncology.

[5]  Lisa D. Stanford,et al.  Confirmatory factor analysis of the Behavior Rating Inventory of Executive Functioning (BRIEF) in children and adolescents with ADHD , 2016, Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence.

[6]  P. Brennan,et al.  Maternal Prenatal Psychological Distress and Preschool Cognitive Functioning: the Protective Role of Positive Parental Engagement , 2016, Journal of Abnormal Child Psychology.

[7]  L. Lagae,et al.  Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. , 2015, The New England journal of medicine.

[8]  J. Kaiser,et al.  Neural correlates of chemotherapy-related cognitive impairment , 2014, Cortex.

[9]  L. Maron,et al.  Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma , 2013, Neurology.

[10]  L. Lagae,et al.  Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. , 2012, The Lancet. Oncology.

[11]  A. Leemans,et al.  Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  T. Vrijkotte,et al.  Antenatal maternal anxiety is associated with problem behaviour at age five. , 2011, Early human development.

[13]  Andrew J. Saykin,et al.  Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study , 2010, Breast Cancer Research and Treatment.

[14]  A. Veerman,et al.  Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: A critical review of the literature , 2009, Pediatric blood & cancer.

[15]  Andrew J. Saykin,et al.  Candidate mechanisms for chemotherapy-induced cognitive changes , 2007, Nature Reviews Cancer.

[16]  E. Vandenbussche,et al.  Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only , 2005, Pediatric blood & cancer.

[17]  Maarten Mennes,et al.  Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. A review , 2005, Neuroscience & Biobehavioral Reviews.

[18]  E. Cardonick,et al.  Use of chemotherapy during human pregnancy. , 2004, The Lancet. Oncology.

[19]  A. Avilés,et al.  Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. , 2001, Clinical lymphoma.

[20]  N. Fisk,et al.  Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study , 1999 .

[21]  R. Gitau,et al.  Fetal exposure to maternal cortisol , 1998, The Lancet.

[22]  S. Waisbren,et al.  Assessing Psychological Functioning in Metabolic Disorders: Validation of the Adaptive Behavior Assessment System, Second Edition (ABAS-II), and the Behavior Rating Inventory of Executive Function (BRIEF) for Identification of Individuals at Risk. , 2015, JIMD reports.

[23]  G. Jackson.  Chemo brain - a psychotropic drug phenomenon? , 2008, Medical hypotheses.